Literature DB >> 10898113

A novel mutation in the flavin-containing monooxygenase 3 gene, FM03, that causes fish-odour syndrome: activity of the mutant enzyme assessed by proton NMR spectroscopy.

H C Murphy1, C T Dolphin, A Janmohamed, H C Holmes, H Michelakakis, E A Shephard, R A Chalmers, I R Phillips, R A Iles.   

Abstract

We have previously shown that primary trimethylaminuria, or fish-odour syndrome, is caused by an inherited defect in the flavin-containing monooxygenase 3 (FMO3) catalysed N-oxidation of the dietary-derived malodorous amine, trimethylamine (TMA). We now report a novel causative mutation for the disorder identified in a young girl diagnosed by proton nuclear magnetic resonance (NMR) spectroscopy of her urine. Sequence analysis of genomic DNA amplified from the patient revealed that she was homozygous for a T to C missense mutation in exon 3 of the FMO3 gene. The mutation changes an ATG triplet, encoding methionine, at codon 82 to an ACG triplet, encoding threonine. A polymerase chain reaction/restriction enzyme-based assay was devised to genotype individuals for the FMO3Thr82 allele. Wild-type and mutant FMO3, heterologously expressed in a baculovirus-insect cell system, were assayed by ultraviolet spectrophotometry and NMR spectroscopy for their ability to catalyse the N-oxidation of TMA. The latter technique has the advantage of enabling the simultaneous, direct and semi-continuous measurement of both of the products, TMA N-oxide and NADP, and of one of the reactants, NADPH. Results obtained from both techniques demonstrate that the Met82Thr mutation abolishes the catalytic activity of the enzyme and thus represents the genetic basis of the disorder in this individual. The combination of NMR spectroscopy with gene sequence and expression technology provides a powerful means of determining genotype-phenotype relationships in trimethylaminuria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898113     DOI: 10.1097/00008571-200007000-00007

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  7 in total

1.  Clinical utility gene card for: trimethylaminuria.

Authors:  Elizabeth A Shephard; Eileen P Treacy; Ian R Phillips
Journal:  Eur J Hum Genet       Date:  2011-11-30       Impact factor: 4.246

Review 2.  Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.

Authors:  Sharon K Krueger; David E Williams
Journal:  Pharmacol Ther       Date:  2005-06       Impact factor: 12.310

3.  Molecular cloning, sequence characterization, SNP detection, and tissue expression analysis of duck FMO3 gene.

Authors:  Peng Wang; Jiangxia Zheng; Lujiang Qu; Ling Lian; Guiyun Xu; Ning Yang
Journal:  Mol Cell Biochem       Date:  2013-04-28       Impact factor: 3.396

4.  Trimethylaminuria: causes and diagnosis of a socially distressing condition.

Authors:  Richard J Mackay; Christopher J McEntyre; Caroline Henderson; Michael Lever; Peter M George
Journal:  Clin Biochem Rev       Date:  2011-02

5.  Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children.

Authors:  R A Chalmers; M D Bain; H Michelakakis; J Zschocke; R A Iles
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

6.  Clinical utility gene card for: Trimethylaminuria - update 2014.

Authors:  Elizabeth A Shephard; Eileen P Treacy; Ian R Phillips
Journal:  Eur J Hum Genet       Date:  2014-10-22       Impact factor: 4.246

7.  A highly sensitive liquid chromatography electrospray ionization mass spectrometry method for quantification of TMA, TMAO and creatinine in mouse urine.

Authors:  Sunil Veeravalli; Kersti Karu; Ian R Phillips; Elizabeth A Shephard
Journal:  MethodsX       Date:  2017-09-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.